Corporate & Investor Presentation
47
Big data analysis demonstrates CPAP treatment
decreases mortality rates by 39%
Objective: to investigate the effects of CPAP therapy use on all-cause mortality in patients with OSA
.
ALASKA study conducted using data from
SNDS, one of the largest anonymized claims
databases in the world representing over 99% of
the French population
-
Included >176,000 people in France
―
New CPAP users aged 18+, initiated
treatment Jan'15-Dec' 16
.
OSA patients who continued CPAP therapy over
the 3-year study period were 39% more likely to
survive than those who discontinued CPAP
therapy
1.
Pepin JL et al. Chest 2022
Survival probability
1.00
0.98
0.96
0.94
CPAP therapy termination
CPAP therapy continuation
HR 0.61, 95% confidence interval [CI] 0.57-0.65;
Log-rank p<0.01
0
0
1
2
3
Time [years]
CPAP treatment is a case of life or death
© 2022 ResMed | Corporate & Investor Presentation - updated 28APR22
ResMedView entire presentation